APO Research
Talk to an analyst

APO RESEARCH · REPORT

ELISA Testing Service

Compare research editions
View pricing & licenses

Selected research

Market Analysis & Forecast

Global ELISA Testing Service Market Analysis and Forecast 2026-2032

3 May 2026195 pages

Choose your research edition.

Industry ResearchELISA Testing Service Industry Research Report 2026139 pages · $2,950 USDIndustry Growth & TrendsGlobal ELISA Testing Service Industry Growth and Trends Forecast to 2032124 pages · $3,450 USDMarket StructureGlobal ELISA Testing Service Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032190 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal ELISA Testing Service Market Outlook and Growth Opportunities 2026190 pages · $4,250 USDMarket Analysis & ForecastGlobal ELISA Testing Service Market Analysis and Forecast 2026-2032195 pages · $4,950 USD

Market perspective

The global ELISA Testing Service market is projected to grow from US$ million in 2026 to US$ million by 2032, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.

The North America market for ELISA Testing Service is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

Europe market for ELISA Testing Service is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

Read the full market overview

Asia-Pacific market for ELISA Testing Service is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

The China market for ELISA Testing Service is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

The major global companies of ELISA Testing Service include Boster Bio, RayBiotech, R&D Systems, Inc, ELISA Technologies, Inc., Cellular Technology Limited, Virology Research Services Ltd, Chimera Biotec, NorthEast BioLab and Sino Biological, Inc, etc. In 2025, the world's top three vendors accounted for approximately % of the revenue.

Report Includes

This report presents an overview of global market for ELISA Testing Service, market size. Analyses of the global market trends, with historic market revenue data for 2021 - 2025, estimates for 2026, and projections of CAGR through 2032.

This report researches the key producers of ELISA Testing Service, also provides the revenue of main regions and countries. Of the upcoming market potential for ELISA Testing Service, and key regions or countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.

This report focuses on the ELISA Testing Service revenue, market share and industry ranking of main manufacturers, data from 2021 to 2026. Identification of the major stakeholders in the global ELISA Testing Service market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.

This report analyzes the segments data by Type and by Application, revenue, and growth rate, from 2021 to 2032. Evaluation and forecast the market size for ELISA Testing Service revenue, projected growth trends, production technology, application and end-user industry.

ELISA Testing Service Segment by Company

Boster Bio

RayBiotech

R&D Systems, Inc

ELISA Technologies, Inc.

Cellular Technology Limited

Virology Research Services Ltd

Chimera Biotec

NorthEast BioLab

Sino Biological, Inc

Kaneka Eurogentec S.A.

Prove Laboratory Services

KCAS Bio

BioCat GmbH

Aviva Systems Biology Corporation

Eve Technologies

Boster Biological Technology

Bio-Techne

Precision Medicine Group, LLC

ACROBiosystems

mabtech

Cellular Technology Limited（immunospot）

Pestka Biomedical Laboratories, Inc

ProteoGenix

Kaneka Eurogentec S.A

ELISA Testing Service Segment by Type

ELISA Test Development

ELISA Test Validation

Others

ELISA Testing Service Segment by Application

Disease Diagnosis

Vaccine Effectiveness Evaluation

Drug Development

Allergen Testing

Others

ELISA Testing Service Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global status and future forecast, involving growth rate (CAGR), market share, historical and forecast.

2. To present the key players, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global ELISA Testing Service market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of ELISA Testing Service and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in market size), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of ELISA Testing Service.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Revenue of ELISA Testing Service in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.

Chapter 4: Detailed analysis of ELISA Testing Service company competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.

Chapter 5: Provides the analysis of various market segments by type, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 6: Provides the analysis of various market segments by application, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 7: Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, ELISA Testing Service revenue, gross margin, and recent development, etc.

Chapter 8: North America by type, by application and by country, revenue for each segment.

Chapter 9: Europe by type, by application and by country, revenue for each segment.

Chapter 10: China type, by application, revenue for each segment.

Chapter 11: Asia (excluding China) type, by application and by region, revenue for each segment.

Chapter 12: South America, Middle East and Africa by type, by application and by country, revenue for each segment.

Chapter 13: The main concluding insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Global ELISA Testing Service Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Table 2. ELISA Test Development Major Player Table 3. ELISA Test Validation Major Player Table 4. Others Major Player Table 5. Global ELISA Testing Service Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Table 6. Disease Diagnosis Major Player Table 7. Vaccine Effectiveness Evaluation Major Player Table 8. Drug Development Major Player Table 9. Allergen Testing Major Player Table 10. Others Major Player Table 11. ELISA Testing Service Industry Trends Table 12. ELISA Testing Service Industry Drivers Table 13. ELISA Testing Service Industry Opportunities and Challenges Table 14. ELISA Testing Service Industry Restraints Table 15. Global ELISA Testing Service Market Size Growth Rate (CAGR) by Region (US$ Million): 2021 VS 2025 VS 2032 Table 16. Global ELISA Testing Service Market Size by Region (2021-2026) & (US$ Million) Table 17. Global ELISA Testing Service Market Share by Region (2021-2026) Table 18. Global ELISA Testing Service Market Size by Region (2027-2032) & (US$ Million) Table 19. Global ELISA Testing Service Market Share by Region (2027-2032) Table 20. Global ELISA Testing Service Revenue by Players (US$ Million) & (2021-2026) Table 21. Global ELISA Testing Service Revenue Market Share by Players (2021-2026) Table 22. Global ELISA Testing Service Key Players Ranking, 2024 VS 2025 VS 2026 Table 23. Global ELISA Testing Service Key Players Headquarters & Area Served Table 24. Global ELISA Testing Service Players, Product Type & Application Table 25. Global ELISA Testing Service Players Establishment Date Table 26. Global Players Market Concentration Ratio (CR5 and HHI) Table 27. Global ELISA Testing Service by Players Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 28. Global ELISA Testing Service Revenue by Type 2021 VS 2025 VS 2032 (US$ Million) Table 29. Global ELISA Testing Service Revenue by Type (2021-2026) & (US$ Million) Table 30. Global ELISA Testing Service Revenue by Type (2027-2032) & (US$ Million) Table 31. Global ELISA Testing Service Revenue Market Share by Type (2021-2026) Table 32. Global ELISA Testing Service Revenue Market Share by Type (2027-2032) Table 33. Global ELISA Testing Service Revenue by Application 2021 VS 2025 VS 2032 (US$ Million) Table 34. Global ELISA Testing Service Revenue by Application (2021-2026) & (US$ Million) Table 35. Global ELISA Testing Service Revenue by Application (2027-2032) & (US$ Million) Table 36. Global ELISA Testing Service Revenue Market Share by Application (2021-2026) Table 37. Global ELISA Testing Service Revenue Market Share by Application (2027-2032) Table 38. Boster Bio Company Information Table 39. Boster Bio Business Overview Table 40. Boster Bio ELISA Testing Service Revenue and Gross Margin (US$ Million) & (2021-2026) Table 41. Boster Bio ELISA Testing Service Product Portfolio Table 42. Boster Bio Recent Development Table 43. RayBiotech Company Information Table 44. RayBiotech Business Overview Table 45. RayBiotech ELISA Testing Service Revenue and Gross Margin (US$ Million) & (2021-2026) Table 46. RayBiotech ELISA Testing Service Product Portfolio Table 47. RayBiotech Recent Development Table 48. R&D Systems, Inc Company Information Table 49. R&D Systems, Inc Business Overview Table 50. R&D Systems, Inc ELISA Testing Service Revenue and Gross Margin (US$ Million) & (2021-2026) Table 51. R&D Systems, Inc ELISA Testing Service Product Portfolio Table 52. R&D Systems, Inc Recent Development Table 53. ELISA Technologies, Inc. Company Information Table 54. ELISA Technologies, Inc. Business Overview Table 55. ELISA Technologies, Inc. ELISA Testing Service Revenue and Gross Margin (US$ Million) & (2021-2026) Table 56. ELISA Technologies, Inc. ELISA Testing Service Product Portfolio Table 57. ELISA Technologies, Inc. Recent Development Table 58. Cellular Technology Limited Company Information Table 59. Cellular Technology Limited Business Overview Table 60. Cellular Technology Limited ELISA Testing Service Revenue and Gross Margin (US$ Million) & (2021-2026) Table 61. Cellular Technology Limited ELISA Testing Service Product Portfolio Table 62. Cellular Technology Limited Recent Development Table 63. Virology Research Services Ltd Company Information Table 64. Virology Research Services Ltd Business Overview Table 65. Virology Research Services Ltd ELISA Testing Service Revenue and Gross Margin (US$ Million) & (2021-2026) Table 66. Virology Research Services Ltd ELISA Testing Service Product Portfolio Table 67. Virology Research Services Ltd Recent Development Table 68. Chimera Biotec Company Information Table 69. Chimera Biotec Business Overview Table 70. Chimera Biotec ELISA Testing Service Revenue and Gross Margin (US$ Million) & (2021-2026) Table 71. Chimera Biotec ELISA Testing Service Product Portfolio Table 72. Chimera Biotec Recent Development Table 73. NorthEast BioLab Company Information Table 74. NorthEast BioLab Business Overview Table 75. NorthEast BioLab ELISA Testing Service Revenue and Gross Margin (US$ Million) & (2021-2026) Table 76. NorthEast BioLab ELISA Testing Service Product Portfolio Table 77. NorthEast BioLab Recent Development Table 78. Sino Biological, Inc Company Information Table 79. Sino Biological, Inc Business Overview Table 80. Sino Biological, Inc ELISA Testing Service Revenue and Gross Margin (US$ Million) & (2021-2026) Table 81. Sino Biological, Inc ELISA Testing Service Product Portfolio Table 82. Sino Biological, Inc Recent Development Table 83. Kaneka Eurogentec S.A. Company Information Table 84. Kaneka Eurogentec S.A. Business Overview Table 85. Kaneka Eurogentec S.A. ELISA Testing Service Revenue and Gross Margin (US$ Million) & (2021-2026) Table 86. Kaneka Eurogentec S.A. ELISA Testing Service Product Portfolio Table 87. Kaneka Eurogentec S.A. Recent Development Table 88. Prove Laboratory Services Company Information Table 89. Prove Laboratory Services Business Overview Table 90. Prove Laboratory Services ELISA Testing Service Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 91. Prove Laboratory Services ELISA Testing Service Product Portfolio Table 92. Prove Laboratory Services Recent Development Table 93. KCAS Bio Company Information Table 94. KCAS Bio Business Overview Table 95. KCAS Bio ELISA Testing Service Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 96. KCAS Bio ELISA Testing Service Product Portfolio Table 97. KCAS Bio Recent Development Table 98. BioCat GmbH Company Information Table 99. BioCat GmbH Business Overview Table 100. BioCat GmbH ELISA Testing Service Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 101. BioCat GmbH ELISA Testing Service Product Portfolio Table 102. BioCat GmbH Recent Development Table 103. Aviva Systems Biology Corporation Company Information Table 104. Aviva Systems Biology Corporation Business Overview Table 105. Aviva Systems Biology Corporation ELISA Testing Service Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 106. Aviva Systems Biology Corporation ELISA Testing Service Product Portfolio Table 107. Aviva Systems Biology Corporation Recent Development Table 108. Eve Technologies Company Information Table 109. Eve Technologies Business Overview Table 110. Eve Technologies ELISA Testing Service Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 111. Eve Technologies ELISA Testing Service Product Portfolio Table 112. Eve Technologies Recent Development Table 113. Boster Biological Technology Company Information Table 114. Boster Biological Technology Business Overview Table 115. Boster Biological Technology ELISA Testing Service Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 116. Boster Biological Technology ELISA Testing Service Product Portfolio Table 117. Boster Biological Technology Recent Development Table 118. Bio-Techne Company Information Table 119. Bio-Techne Business Overview Table 120. Bio-Techne ELISA Testing Service Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 121. Bio-Techne ELISA Testing Service Product Portfolio Table 122. Bio-Techne Recent Development Table 123. Precision Medicine Group, LLC Company Information Table 124. Precision Medicine Group, LLC Business Overview Table 125. Precision Medicine Group, LLC ELISA Testing Service Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 126. Precision Medicine Group, LLC ELISA Testing Service Product Portfolio Table 127. Precision Medicine Group, LLC Recent Development Table 128. ACROBiosystems Company Information Table 129. ACROBiosystems Business Overview Table 130. ACROBiosystems ELISA Testing Service Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 131. ACROBiosystems ELISA Testing Service Product Portfolio Table 132. ACROBiosystems Recent Development Table 133. mabtech Company Information Table 134. mabtech Business Overview Table 135. mabtech ELISA Testing Service Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 136. mabtech ELISA Testing Service Product Portfolio Table 137. mabtech Recent Development Table 138. Cellular Technology Limited（immunospot） Company Information Table 139. Cellular Technology Limited（immunospot） Business Overview Table 140. Cellular Technology Limited（immunospot） ELISA Testing Service Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 141. Cellular Technology Limited（immunospot） ELISA Testing Service Product Portfolio Table 142. Cellular Technology Limited（immunospot） Recent Development Table 143. Pestka Biomedical Laboratories, Inc Company Information Table 144. Pestka Biomedical Laboratories, Inc Business Overview Table 145. Pestka Biomedical Laboratories, Inc ELISA Testing Service Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 146. Pestka Biomedical Laboratories, Inc ELISA Testing Service Product Portfolio Table 147. Pestka Biomedical Laboratories, Inc Recent Development Table 148. ProteoGenix Company Information Table 149. ProteoGenix Business Overview Table 150. ProteoGenix ELISA Testing Service Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 151. ProteoGenix ELISA Testing Service Product Portfolio Table 152. ProteoGenix Recent Development Table 153. Kaneka Eurogentec S.A Company Information Table 154. Kaneka Eurogentec S.A Business Overview Table 155. Kaneka Eurogentec S.A ELISA Testing Service Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 156. Kaneka Eurogentec S.A ELISA Testing Service Product Portfolio Table 157. Kaneka Eurogentec S.A Recent Development Table 158. North America ELISA Testing Service Revenue by Type (2021-2026) & (US$ Million) Table 159. North America ELISA Testing Service Revenue by Type (2027-2032) & (US$ Million) Table 160. North America ELISA Testing Service Revenue by Application (2021-2026) & (US$ Million) Table 161. North America ELISA Testing Service Revenue by Application (2027-2032) & (US$ Million) Table 162. North America ELISA Testing Service Revenue by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 163. North America ELISA Testing Service Revenue by Country (2021-2026) & (US$ Million) Table 164. North America ELISA Testing Service Revenue by Country (US$ Million) & (2027-2032) Table 165. Europe ELISA Testing Service Revenue by Type (2021-2026) & (US$ Million) Table 166. Europe ELISA Testing Service Revenue by Type (2027-2032) & (US$ Million) Table 167. Europe ELISA Testing Service Revenue by Application (2021-2026) & (US$ Million) Table 168. Europe ELISA Testing Service Revenue by Application (2027-2032) & (US$ Million) Table 169. Europe ELISA Testing Service Revenue by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 170. Europe ELISA Testing Service Revenue by Country (2021-2026) & (US$ Million) Table 171. Europe ELISA Testing Service Revenue by Country (US$ Million) & (2027-2032) Table 172. China ELISA Testing Service Revenue by Type (2021-2026) & (US$ Million) Table 173. China ELISA Testing Service Revenue by Type (2027-2032) & (US$ Million) Table 174. China ELISA Testing Service Revenue by Application (2021-2026) & (US$ Million) Table 175. China ELISA Testing Service Revenue by Application (2027-2032) & (US$ Million) Table 176. Asia ELISA Testing Service Revenue by Type (2021-2026) & (US$ Million) Table 177. Asia ELISA Testing Service Revenue by Type (2027-2032) & (US$ Million) Table 178. Asia ELISA Testing Service Revenue by Application (2021-2026) & (US$ Million) Table 179. Asia ELISA Testing Service Revenue by Application (2027-2032) & (US$ Million) Table 180. Asia ELISA Testing Service Revenue by Region (2021 VS 2025 VS 2032) & (US$ Million) Table 181. Asia ELISA Testing Service Revenue by Region (US$ Million) & (2021-2026) Table 182. Asia ELISA Testing Service Revenue by Region (US$ Million) & (2027-2032) Table 183. SAMEA ELISA Testing Service Revenue by Type (2021-2026) & (US$ Million) Table 184. SAMEA ELISA Testing Service Revenue by Type (2027-2032) & (US$ Million) Table 185. SAMEA ELISA Testing Service Revenue by Application (2021-2026) & (US$ Million) Table 186. SAMEA ELISA Testing Service Revenue by Application (2027-2032) & (US$ Million) Table 187. SAMEA ELISA Testing Service Revenue by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 188. SAMEA ELISA Testing Service Revenue by Country (2021-2026) & (US$ Million) Table 189. SAMEA ELISA Testing Service Revenue by Country (US$ Million) & (2027-2032) Table 190. Research Programs/Design for This Report Table 191. Authors List of This Report Table 192. Secondary Sources Table 193. Primary Sources List of Figures Figure 1. ELISA Testing Service Image Figure 2. Global ELISA Testing Service Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global ELISA Testing Service Market Size Share 2021 VS 2025 VS 2032 Figure 4. ELISA Test Development Image Figure 5. ELISA Test Validation Image Figure 6. Others Image Figure 7. Global ELISA Testing Service Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Figure 8. Global ELISA Testing Service Market Size Share 2021 VS 2025 VS 2032 Figure 9. Disease Diagnosis Image Figure 10. Vaccine Effectiveness Evaluation Image Figure 11. Drug Development Image Figure 12. Allergen Testing Image Figure 13. Others Image Figure 14. Global ELISA Testing Service Market Size (US$ Million) & (2021-2032) Figure 15. Global ELISA Testing Service Market Size, (US$ Million), 2021 VS 2025 VS 2032 Figure 16. Global ELISA Testing Service Market Share by Region: 2021 VS 2025 VS 2032 Figure 17. Global ELISA Testing Service Players Revenue Share Top 10 and Top 5 in 2025 Figure 18. Players Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 19. Global ELISA Testing Service Revenue by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 20. Global ELISA Testing Service Revenue Market Share 2021 VS 2025 VS 2032 Figure 21. Global ELISA Testing Service Revenue Market Share by Type (2021-2032) Figure 22. Global ELISA Testing Service Revenue by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 23. Global ELISA Testing Service Revenue Market Share by Application (2021 VS 2025 VS 2032) Figure 24. Global ELISA Testing Service Revenue Market Share by Application (2021-2032) Figure 25. North America ELISA Testing Service Revenue YoY Growth (2021-2032) & (US$ Million) Figure 26. North America ELISA Testing Service Revenue Share by Type (2021-2032) Figure 27. North America ELISA Testing Service Revenue Share by Application (2021-2032) Figure 28. North America ELISA Testing Service Revenue Share by Country (2021-2032) Figure 29. United States ELISA Testing Service Revenue YoY Growth (US$ Million) & (2021-2032) Figure 30. Canada ELISA Testing Service Revenue YoY Growth (US$ Million) & (2021-2032) Figure 31. Mexico ELISA Testing Service Revenue YoY Growth (US$ Million) & (2021-2032) Figure 32. Europe ELISA Testing Service Revenue YoY Growth (2021-2032) & (US$ Million) Figure 33. Europe ELISA Testing Service Revenue Share by Type (2021-2032) Figure 34. Europe ELISA Testing Service Revenue Share by Application (2021-2032) Figure 35. Europe ELISA Testing Service Revenue Share by Country (2021-2032) Figure 36. Germany ELISA Testing Service Revenue YoY Growth (US$ Million) & (2021-2032) Figure 37. France ELISA Testing Service Revenue YoY Growth (US$ Million) & (2021-2032) Figure 38. U.K. ELISA Testing Service Revenue YoY Growth (US$ Million) & (2021-2032) Figure 39. Italy ELISA Testing Service Revenue YoY Growth (US$ Million) & (2021-2032) Figure 40. Spain ELISA Testing Service Revenue YoY Growth (US$ Million) & (2021-2032) Figure 41. Russia ELISA Testing Service Revenue YoY Growth (US$ Million) & (2021-2032) Figure 42. Netherlands ELISA Testing Service Revenue YoY Growth (US$ Million) & (2021-2032) Figure 43. Nordic Countries ELISA Testing Service Revenue YoY Growth (US$ Million) & (2021-2032) Figure 44. China ELISA Testing Service Revenue YoY Growth (2021-2032) & (US$ Million) Figure 45. China ELISA Testing Service Revenue Share by Type (2021-2032) Figure 46. China ELISA Testing Service Revenue Share by Application (2021-2032) Figure 47. Asia ELISA Testing Service Revenue YoY Growth (2021-2032) & (US$ Million) Figure 48. Asia ELISA Testing Service Revenue Share by Type (2021-2032) Figure 49. Asia ELISA Testing Service Revenue Share by Application (2021-2032) Figure 50. Asia ELISA Testing Service Revenue Share by Region (2021-2032) Figure 51. Japan ELISA Testing Service Revenue YoY Growth (US$ Million) & (2021-2032) Figure 52. South Korea ELISA Testing Service Revenue YoY Growth (US$ Million) & (2021-2032) Figure 53. India ELISA Testing Service Revenue YoY Growth (US$ Million) & (2021-2032) Figure 54. Australia ELISA Testing Service Revenue YoY Growth (US$ Million) & (2021-2032) Figure 55. Taiwan ELISA Testing Service Revenue YoY Growth (US$ Million) & (2021-2032) Figure 56. Southeast Asia ELISA Testing Service Revenue YoY Growth (US$ Million) & (2021-2032) Figure 57. SAMEA ELISA Testing Service Revenue YoY Growth (2021-2032) & (US$ Million) Figure 58. SAMEA ELISA Testing Service Revenue Share by Type (2021-2032) Figure 59. SAMEA ELISA Testing Service Revenue Share by Application (2021-2032) Figure 60. SAMEA ELISA Testing Service Revenue Share by Country (2021-2032) Figure 61. Brazil ELISA Testing Service Revenue YoY Growth (US$ Million) & (2021-2032) Figure 62. Argentina ELISA Testing Service Revenue YoY Growth (US$ Million) & (2021-2032) Figure 63. Chile ELISA Testing Service Revenue YoY Growth (US$ Million) & (2021-2032) Figure 64. Colombia ELISA Testing Service Revenue YoY Growth (US$ Million) & (2021-2032) Figure 65. Peru ELISA Testing Service Revenue YoY Growth (US$ Million) & (2021-2032) Figure 66. Saudi Arabia ELISA Testing Service Revenue YoY Growth (US$ Million) & (2021-2032) Figure 67. Israel ELISA Testing Service Revenue YoY Growth (US$ Million) & (2021-2032) Figure 68. UAE ELISA Testing Service Revenue YoY Growth (US$ Million) & (2021-2032) Figure 69. Turkey ELISA Testing Service Revenue YoY Growth (US$ Million) & (2021-2032) Figure 70. Iran ELISA Testing Service Revenue YoY Growth (US$ Million) & (2021-2032) Figure 71. Egypt ELISA Testing Service Revenue YoY Growth (US$ Million) & (2021-2032) Figure 72. Years Considered Figure 73. Research Process Figure 74. Key Executives Interviewed

Scope & coverage.

Types
  • ELISA Test Development
  • ELISA Test Validation
  • Others
Applications
  • Disease Diagnosis
  • Vaccine Effectiveness Evaluation
  • Drug Development
  • Allergen Testing
  • Others
Companies covered
  • Boster Bio
  • RayBiotech
  • R&D Systems, Inc
  • ELISA Technologies, Inc.
  • Cellular Technology Limited
  • Virology Research Services Ltd
  • Chimera Biotec
  • NorthEast BioLab
  • Sino Biological, Inc
  • Kaneka Eurogentec S.A.
  • Prove Laboratory Services
  • KCAS Bio
  • BioCat GmbH
  • Aviva Systems Biology Corporation
  • Eve Technologies
  • Boster Biological Technology
  • Bio-Techne
  • Precision Medicine Group, LLC
  • ACROBiosystems
  • mabtech
  • Cellular Technology Limited（immunospot）
  • Pestka Biomedical Laboratories, Inc
  • ProteoGenix
  • Kaneka Eurogentec S.A

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 ELISA Testing Service Market by Type
  3. 1.2.1 Global ELISA Testing Service Market Size by Type, 2021 VS 2025 VS 2032
  4. 1.2.2 ELISA Test Development
  5. 1.2.3 ELISA Test Validation
  6. 1.2.4 Others
  7. 1.3 ELISA Testing Service Market by Application
  8. 1.3.1 Global ELISA Testing Service Market Size by Application, 2021 VS 2025 VS 2032
  9. 1.3.2 Disease Diagnosis
  10. 1.3.3 Vaccine Effectiveness Evaluation
  11. 1.3.4 Drug Development
  12. 1.3.5 Allergen Testing
  13. 1.3.6 Others
  14. 1.4 Assumptions and Limitations
  15. 1.5 Study Goals and Objectives
2 ELISA Testing Service Market Dynamics
  1. 2.1 ELISA Testing Service Industry Trends
  2. 2.2 ELISA Testing Service Industry Drivers
  3. 2.3 ELISA Testing Service Industry Opportunities and Challenges
  4. 2.4 ELISA Testing Service Industry Restraints
3 Global Growth Perspective
  1. 3.1 Global ELISA Testing Service Market Perspective (2021-2032)
  2. 3.2 Global ELISA Testing Service Growth Trends by Region
  3. 3.2.1 Global ELISA Testing Service Market Size by Region: 2021 VS 2025 VS 2032
  4. 3.2.2 Global ELISA Testing Service Market Size by Region (2021-2026)
  5. 3.2.3 Global ELISA Testing Service Market Size by Region (2027-2032)
4 Competitive Landscape by Players
  1. 4.1 Global ELISA Testing Service Revenue by Players
  2. 4.1.1 Global ELISA Testing Service Revenue by Players (2021-2026)
  3. 4.1.2 Global ELISA Testing Service Revenue Market Share by Players (2021-2026)
  4. 4.1.3 Global ELISA Testing Service Players Revenue Share Top 10 and Top 5 in 2025
  5. 4.2 Global ELISA Testing Service Key Players Ranking, 2024 VS 2025 VS 2026
  6. 4.3 Global ELISA Testing Service Key Players Headquarters & Area Served
  7. 4.4 Global ELISA Testing Service Players, Product Type & Application
  8. 4.5 Global ELISA Testing Service Players Establishment Date
  9. 4.6 Market Competitive Analysis
  10. 4.6.1 Global ELISA Testing Service Market CR5 and HHI
  11. 4.6.3 2025 ELISA Testing Service Tier 1, Tier 2, and Tier 3
5 ELISA Testing Service Market Size by Type
  1. 5.1 Global ELISA Testing Service Revenue by Type (2021 VS 2025 VS 2032)
  2. 5.2 Global ELISA Testing Service Revenue by Type (2021-2032)
  3. 5.3 Global ELISA Testing Service Revenue Market Share by Type (2021-2032)
6 ELISA Testing Service Market Size by Application
  1. 6.1 Global ELISA Testing Service Revenue by Application (2021 VS 2025 VS 2032)
  2. 6.2 Global ELISA Testing Service Revenue by Application (2021-2032)
  3. 6.3 Global ELISA Testing Service Revenue Market Share by Application (2021-2032)
7 Company Profiles
  1. 7.1 Boster Bio
  2. 7.1.1 Boster Bio Company Information
  3. 7.1.2 Boster Bio Business Overview
  4. 7.1.3 Boster Bio ELISA Testing Service Revenue and Gross Margin (2021-2026)
  5. 7.1.4 Boster Bio ELISA Testing Service Product Portfolio
  6. 7.1.5 Boster Bio Recent Developments
  7. 7.2 RayBiotech
  8. 7.2.1 RayBiotech Company Information
  9. 7.2.2 RayBiotech Business Overview
  10. 7.2.3 RayBiotech ELISA Testing Service Revenue and Gross Margin (2021-2026)
  11. 7.2.4 RayBiotech ELISA Testing Service Product Portfolio
  12. 7.2.5 RayBiotech Recent Developments
  13. 7.3 R&D Systems, Inc
  14. 7.3.1 R&D Systems, Inc Company Information
  15. 7.3.2 R&D Systems, Inc Business Overview
  16. 7.3.3 R&D Systems, Inc ELISA Testing Service Revenue and Gross Margin (2021-2026)
  17. 7.3.4 R&D Systems, Inc ELISA Testing Service Product Portfolio
  18. 7.3.5 R&D Systems, Inc Recent Developments
  19. 7.4 ELISA Technologies, Inc.
  20. 7.4.1 ELISA Technologies, Inc. Company Information
  21. 7.4.2 ELISA Technologies, Inc. Business Overview
  22. 7.4.3 ELISA Technologies, Inc. ELISA Testing Service Revenue and Gross Margin (2021-2026)
  23. 7.4.4 ELISA Technologies, Inc. ELISA Testing Service Product Portfolio
  24. 7.4.5 ELISA Technologies, Inc. Recent Developments
  25. 7.5 Cellular Technology Limited
  26. 7.5.1 Cellular Technology Limited Company Information
  27. 7.5.2 Cellular Technology Limited Business Overview
  28. 7.5.3 Cellular Technology Limited ELISA Testing Service Revenue and Gross Margin (2021-2026)
  29. 7.5.4 Cellular Technology Limited ELISA Testing Service Product Portfolio
  30. 7.5.5 Cellular Technology Limited Recent Developments
  31. 7.6 Virology Research Services Ltd
  32. 7.6.1 Virology Research Services Ltd Company Information
  33. 7.6.2 Virology Research Services Ltd Business Overview
  34. 7.6.3 Virology Research Services Ltd ELISA Testing Service Revenue and Gross Margin (2021-2026)
  35. 7.6.4 Virology Research Services Ltd ELISA Testing Service Product Portfolio
  36. 7.6.5 Virology Research Services Ltd Recent Developments
  37. 7.7 Chimera Biotec
  38. 7.7.1 Chimera Biotec Company Information
  39. 7.7.2 Chimera Biotec Business Overview
  40. 7.7.3 Chimera Biotec ELISA Testing Service Revenue and Gross Margin (2021-2026)
  41. 7.7.4 Chimera Biotec ELISA Testing Service Product Portfolio
  42. 7.7.5 Chimera Biotec Recent Developments
  43. 7.8 NorthEast BioLab
  44. 7.8.1 NorthEast BioLab Company Information
  45. 7.8.2 NorthEast BioLab Business Overview
  46. 7.8.3 NorthEast BioLab ELISA Testing Service Revenue and Gross Margin (2021-2026)
  47. 7.8.4 NorthEast BioLab ELISA Testing Service Product Portfolio
  48. 7.8.5 NorthEast BioLab Recent Developments
  49. 7.9 Sino Biological, Inc
  50. 7.9.1 Sino Biological, Inc Company Information
  51. 7.9.2 Sino Biological, Inc Business Overview
  52. 7.9.3 Sino Biological, Inc ELISA Testing Service Revenue and Gross Margin (2021-2026)
  53. 7.9.4 Sino Biological, Inc ELISA Testing Service Product Portfolio
  54. 7.9.5 Sino Biological, Inc Recent Developments
  55. 7.10 Kaneka Eurogentec S.A.
  56. 7.10.1 Kaneka Eurogentec S.A. Company Information
  57. 7.10.2 Kaneka Eurogentec S.A. Business Overview
  58. 7.10.3 Kaneka Eurogentec S.A. ELISA Testing Service Revenue and Gross Margin (2021-2026)
  59. 7.10.4 Kaneka Eurogentec S.A. ELISA Testing Service Product Portfolio
  60. 7.10.5 Kaneka Eurogentec S.A. Recent Developments
  61. 7.11 Prove Laboratory Services
  62. 7.11.1 Prove Laboratory Services Company Information
  63. 7.11.2 Prove Laboratory Services Business Overview
  64. 7.11.3 Prove Laboratory Services ELISA Testing Service Revenue and Gross Margin (2021-2026)
  65. 7.11.4 Prove Laboratory Services ELISA Testing Service Product Portfolio
  66. 7.11.5 Prove Laboratory Services Recent Developments
  67. 7.12 KCAS Bio
  68. 7.12.1 KCAS Bio Company Information
  69. 7.12.2 KCAS Bio Business Overview
  70. 7.12.3 KCAS Bio ELISA Testing Service Revenue and Gross Margin (2021-2026)
  71. 7.12.4 KCAS Bio ELISA Testing Service Product Portfolio
  72. 7.12.5 KCAS Bio Recent Developments
  73. 7.13 BioCat GmbH
  74. 7.13.1 BioCat GmbH Company Information
  75. 7.13.2 BioCat GmbH Business Overview
  76. 7.13.3 BioCat GmbH ELISA Testing Service Revenue and Gross Margin (2021-2026)
  77. 7.13.4 BioCat GmbH ELISA Testing Service Product Portfolio
  78. 7.13.5 BioCat GmbH Recent Developments
  79. 7.14 Aviva Systems Biology Corporation
  80. 7.14.1 Aviva Systems Biology Corporation Company Information
  81. 7.14.2 Aviva Systems Biology Corporation Business Overview
  82. 7.14.3 Aviva Systems Biology Corporation ELISA Testing Service Revenue and Gross Margin (2021-2026)
  83. 7.14.4 Aviva Systems Biology Corporation ELISA Testing Service Product Portfolio
  84. 7.14.5 Aviva Systems Biology Corporation Recent Developments
  85. 7.15 Eve Technologies
  86. 7.15.1 Eve Technologies Company Information
  87. 7.15.2 Eve Technologies Business Overview
  88. 7.15.3 Eve Technologies ELISA Testing Service Revenue and Gross Margin (2021-2026)
  89. 7.15.4 Eve Technologies ELISA Testing Service Product Portfolio
  90. 7.15.5 Eve Technologies Recent Developments
  91. 7.16 Boster Biological Technology
  92. 7.16.1 Boster Biological Technology Company Information
  93. 7.16.2 Boster Biological Technology Business Overview
  94. 7.16.3 Boster Biological Technology ELISA Testing Service Revenue and Gross Margin (2021-2026)
  95. 7.16.4 Boster Biological Technology ELISA Testing Service Product Portfolio
  96. 7.16.5 Boster Biological Technology Recent Developments
  97. 7.17 Bio-Techne
  98. 7.17.1 Bio-Techne Company Information
  99. 7.17.2 Bio-Techne Business Overview
  100. 7.17.3 Bio-Techne ELISA Testing Service Revenue and Gross Margin (2021-2026)
  101. 7.17.4 Bio-Techne ELISA Testing Service Product Portfolio
  102. 7.17.5 Bio-Techne Recent Developments
  103. 7.18 Precision Medicine Group, LLC
  104. 7.18.1 Precision Medicine Group, LLC Company Information
  105. 7.18.2 Precision Medicine Group, LLC Business Overview
  106. 7.18.3 Precision Medicine Group, LLC ELISA Testing Service Revenue and Gross Margin (2021-2026)
  107. 7.18.4 Precision Medicine Group, LLC ELISA Testing Service Product Portfolio
  108. 7.18.5 Precision Medicine Group, LLC Recent Developments
  109. 7.19 ACROBiosystems
  110. 7.19.1 ACROBiosystems Company Information
  111. 7.19.2 ACROBiosystems Business Overview
  112. 7.19.3 ACROBiosystems ELISA Testing Service Revenue and Gross Margin (2021-2026)
  113. 7.19.4 ACROBiosystems ELISA Testing Service Product Portfolio
  114. 7.19.5 ACROBiosystems Recent Developments
  115. 7.20 mabtech
  116. 7.20.1 mabtech Company Information
  117. 7.20.2 mabtech Business Overview
  118. 7.20.3 mabtech ELISA Testing Service Revenue and Gross Margin (2021-2026)
  119. 7.20.4 mabtech ELISA Testing Service Product Portfolio
  120. 7.20.5 mabtech Recent Developments
  121. 7.21 Cellular Technology Limited（immunospot）
  122. 7.21.1 Cellular Technology Limited（immunospot） Company Information
  123. 7.21.2 Cellular Technology Limited（immunospot） Business Overview
  124. 7.21.3 Cellular Technology Limited（immunospot） ELISA Testing Service Revenue and Gross Margin (2021-2026)
  125. 7.21.4 Cellular Technology Limited（immunospot） ELISA Testing Service Product Portfolio
  126. 7.21.5 Cellular Technology Limited（immunospot） Recent Developments
  127. 7.22 Pestka Biomedical Laboratories, Inc
  128. 7.22.1 Pestka Biomedical Laboratories, Inc Company Information
  129. 7.22.2 Pestka Biomedical Laboratories, Inc Business Overview
  130. 7.22.3 Pestka Biomedical Laboratories, Inc ELISA Testing Service Revenue and Gross Margin (2021-2026)
  131. 7.22.4 Pestka Biomedical Laboratories, Inc ELISA Testing Service Product Portfolio
  132. 7.22.5 Pestka Biomedical Laboratories, Inc Recent Developments
  133. 7.23 ProteoGenix
  134. 7.23.1 ProteoGenix Company Information
  135. 7.23.2 ProteoGenix Business Overview
  136. 7.23.3 ProteoGenix ELISA Testing Service Revenue and Gross Margin (2021-2026)
  137. 7.23.4 ProteoGenix ELISA Testing Service Product Portfolio
  138. 7.23.5 ProteoGenix Recent Developments
  139. 7.24 Kaneka Eurogentec S.A
  140. 7.24.1 Kaneka Eurogentec S.A Company Information
  141. 7.24.2 Kaneka Eurogentec S.A Business Overview
  142. 7.24.3 Kaneka Eurogentec S.A ELISA Testing Service Revenue and Gross Margin (2021-2026)
  143. 7.24.4 Kaneka Eurogentec S.A ELISA Testing Service Product Portfolio
  144. 7.24.5 Kaneka Eurogentec S.A Recent Developments
8 North America
  1. 8.1 North America ELISA Testing Service Revenue (2021-2032)
  2. 8.2 North America ELISA Testing Service Revenue by Type (2021-2032)
  3. 8.2.1 North America ELISA Testing Service Revenue by Type (2021-2026)
  4. 8.2.2 North America ELISA Testing Service Revenue by Type (2027-2032)
  5. 8.3 North America ELISA Testing Service Revenue Share by Type (2021-2032)
  6. 8.4 North America ELISA Testing Service Revenue by Application (2021-2032)
  7. 8.4.1 North America ELISA Testing Service Revenue by Application (2021-2026)
  8. 8.4.2 North America ELISA Testing Service Revenue by Application (2027-2032)
  9. 8.5 North America ELISA Testing Service Revenue Share by Application (2021-2032)
  10. 8.6 North America ELISA Testing Service Revenue by Country
  11. 8.6.1 North America ELISA Testing Service Revenue by Country (2021 VS 2025 VS 2032)
  12. 8.6.2 North America ELISA Testing Service Revenue by Country (2021-2026)
  13. 8.6.3 North America ELISA Testing Service Revenue by Country (2027-2032)
  14. 8.6.4 United States
  15. 8.6.5 Canada
  16. 8.6.6 Mexico
9 Europe
  1. 9.1 Europe ELISA Testing Service Revenue (2021-2032)
  2. 9.2 Europe ELISA Testing Service Revenue by Type (2021-2032)
  3. 9.2.1 Europe ELISA Testing Service Revenue by Type (2021-2026)
  4. 9.2.2 Europe ELISA Testing Service Revenue by Type (2027-2032)
  5. 9.3 Europe ELISA Testing Service Revenue Share by Type (2021-2032)
  6. 9.4 Europe ELISA Testing Service Revenue by Application (2021-2032)
  7. 9.4.1 Europe ELISA Testing Service Revenue by Application (2021-2026)
  8. 9.4.2 Europe ELISA Testing Service Revenue by Application (2027-2032)
  9. 9.5 Europe ELISA Testing Service Revenue Share by Application (2021-2032)
  10. 9.6 Europe ELISA Testing Service Revenue by Country
  11. 9.6.1 Europe ELISA Testing Service Revenue by Country (2021 VS 2025 VS 2032)
  12. 9.6.2 Europe ELISA Testing Service Revenue by Country (2021-2026)
  13. 9.6.3 Europe ELISA Testing Service Revenue by Country (2027-2032)
  14. 9.6.4 Germany
  15. 9.6.5 France
  16. 9.6.6 U.K.
  17. 9.6.7 Italy
  18. 9.6.8 Russia
  19. 9.6.9 Spain
  20. 9.6.10 Netherlands
  21. 9.6.11 Switzerland
  22. 9.6.12 Sweden
  23. 9.6.13 Poland
10 China
  1. 10.1 China ELISA Testing Service Revenue (2021-2032)
  2. 10.2 China ELISA Testing Service Revenue by Type (2021-2032)
  3. 10.2.1 China ELISA Testing Service Revenue by Type (2021-2026)
  4. 10.2.2 China ELISA Testing Service Revenue by Type (2027-2032)
  5. 10.3 China ELISA Testing Service Revenue Share by Type (2021-2032)
  6. 10.4 China ELISA Testing Service Revenue by Application (2021-2032)
  7. 10.4.1 China ELISA Testing Service Revenue by Application (2021-2026)
  8. 10.4.2 China ELISA Testing Service Revenue by Application (2027-2032)
  9. 10.5 China ELISA Testing Service Revenue Share by Application (2021-2032)
11 Asia (Excluding China)
  1. 11.1 Asia ELISA Testing Service Revenue (2021-2032)
  2. 11.2 Asia ELISA Testing Service Revenue by Type (2021-2032)
  3. 11.2.1 Asia ELISA Testing Service Revenue by Type (2021-2026)
  4. 11.2.2 Asia ELISA Testing Service Revenue by Type (2027-2032)
  5. 11.3 Asia ELISA Testing Service Revenue Share by Type (2021-2032)
  6. 11.4 Asia ELISA Testing Service Revenue by Application (2021-2032)
  7. 11.4.1 Asia ELISA Testing Service Revenue by Application (2021-2026)
  8. 11.4.2 Asia ELISA Testing Service Revenue by Application (2027-2032)
  9. 11.5 Asia ELISA Testing Service Revenue Share by Application (2021-2032)
  10. 11.6 Asia ELISA Testing Service Revenue by Country
  11. 11.6.1 Asia ELISA Testing Service Revenue by Country (2021 VS 2025 VS 2032)
  12. 11.6.2 Asia ELISA Testing Service Revenue by Country (2021-2026)
  13. 11.6.3 Asia ELISA Testing Service Revenue by Country (2027-2032)
  14. 11.6.4 Japan
  15. 11.6.5 South Korea
  16. 11.6.6 India
  17. 11.6.7 Australia
  18. 11.6.8 Taiwan
  19. 11.6.9 Southeast Asia
12 South America, Middle East and Africa
  1. 12.1 SAMEA ELISA Testing Service Revenue (2021-2032)
  2. 12.2 SAMEA ELISA Testing Service Revenue by Type (2021-2032)
  3. 12.2.1 SAMEA ELISA Testing Service Revenue by Type (2021-2026)
  4. 12.2.2 SAMEA ELISA Testing Service Revenue by Type (2027-2032)
  5. 12.3 SAMEA ELISA Testing Service Revenue Share by Type (2021-2032)
  6. 12.4 SAMEA ELISA Testing Service Revenue by Application (2021-2032)
  7. 12.4.1 SAMEA ELISA Testing Service Revenue by Application (2021-2026)
  8. 12.4.2 SAMEA ELISA Testing Service Revenue by Application (2027-2032)
  9. 12.5 SAMEA ELISA Testing Service Revenue Share by Application (2021-2032)
  10. 12.6 SAMEA ELISA Testing Service Revenue by Country
  11. 12.6.1 SAMEA ELISA Testing Service Revenue by Country (2021 VS 2025 VS 2032)
  12. 12.6.2 SAMEA ELISA Testing Service Revenue by Country (2021-2026)
  13. 12.6.3 SAMEA ELISA Testing Service Revenue by Country (2027-2032)
  14. 12.6.4 Brazil
  15. 12.6.5 Argentina
  16. 12.6.6 Chile
  17. 12.6.7 Colombia
  18. 12.6.8 Peru
  19. 12.6.9 Saudi Arabia
  20. 12.6.10 Israel
  21. 12.6.11 UAE
  22. 12.6.12 Turkey
  23. 12.6.13 Iran
  24. 12.6.14 Egypt
13 Concluding Insights
    14 Appendix
    1. 14.1 Reasons for Doing This Study
    2. 14.2 Research Methodology
    3. 14.3 Research Process
    4. 14.4 Authors List of This Report
    5. 14.5 Data Source
    6. 14.5.1 Secondary Sources
    7. 14.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst